Pfizer's RSV shot Abrysvo was cleared by the FDA last October for the 18 to 59 age group, extending its 2023 approval in the ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

Changing a cultural undertow is one of the hardest leadership challenges in any industry, and perhaps even more so in the ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

The Health and Human Services (HHS) Secretary named eight hand-picked members of the Advisory Committee on Immunisation ...

At ASCO 2025, ImmunityBio’s chief medical officer, Dr Sandeep Reddy, spoke with pharmaphorum about the importance of FDA ...